Special issue of AJTMH focuses on low quality medicines in the developing world
Access to high-quality medicine is a basic human right, but more than four billion people live in countries where many medications are substandard or fake. Marya Lieberman of the Department of Chemistry and Biochemistry at the University of Notre Dame and Abigail Weaver, a postdoctoral associate in the University’s Department of Civil Engineering and Environmental and Earth Sciences, took up the challenge of how people in developing countries could detect low-quality antimalarial drugs without expensive equipment and without handling dangerous chemicals.